VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21 | 0.0% | 3,142 | 0.0% | 0.00% | – |
| Q2 2023 | $21 | 0.0% | 3,142 | 0.0% | 0.00% | – |
| Q1 2023 | $21 | -61.1% | 3,142 | -42.7% | 0.00% | – |
| Q4 2022 | $54 | -99.9% | 5,483 | 0.0% | 0.00% | – |
| Q3 2022 | $54,000 | -10.0% | 5,483 | 0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -51.2% | 5,483 | -49.6% | 0.00% | – |
| Q1 2022 | $123,000 | -62.7% | 10,872 | -48.4% | 0.00% | -100.0% |
| Q4 2021 | $330,000 | -8.6% | 21,060 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $361,000 | -60.2% | 21,060 | -50.0% | 0.00% | -50.0% |
| Q2 2021 | $906,000 | +43.4% | 42,120 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $632,000 | -43.4% | 42,120 | +172.6% | 0.00% | – |
| Q4 2020 | $1,117,000 | +644.7% | 15,452 | 0.0% | 0.00% | – |
| Q3 2020 | $150,000 | -14.8% | 15,452 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $176,000 | – | 15,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |